M Sakurai

601 total citations
34 papers, 447 citations indexed

About

M Sakurai is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, M Sakurai has authored 34 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Public Health, Environmental and Occupational Health and 5 papers in Oncology. Recurrent topics in M Sakurai's work include Acute Lymphoblastic Leukemia research (7 papers), Plant Pathogens and Fungal Diseases (3 papers) and T-cell and Retrovirus Studies (2 papers). M Sakurai is often cited by papers focused on Acute Lymphoblastic Leukemia research (7 papers), Plant Pathogens and Fungal Diseases (3 papers) and T-cell and Retrovirus Studies (2 papers). M Sakurai collaborates with scholars based in Japan, Australia and Greece. M Sakurai's co-authors include Yasuhiko Kaneko, Nobuo Maseki, T Shikano, T Fujimoto, Yoshihiro Komada, T. Takeda, H Kamiya, Kazuo Maruyama, Masahiko Matsumura and Yoshihide Mitani and has published in prestigious journals such as Blood, Scientific Reports and Thorax.

In The Last Decade

M Sakurai

28 papers receiving 423 citations

Peers

M Sakurai
Comparison fields: 5 of 73
  • Hematology 192
  • Molecular Biology 129
  • Public Health, Environmental and Occupational Health 112
  • Immunology 76
  • Epidemiology 62
Replace Liesbeth van Emst with:
Liesbeth van Emst Netherlands
T Sylwestrowicz United Kingdom
Frank Stolz Austria
Claudia Schubert Germany
Norma B de Bosch Venezuela
José Luís Dapena Spain
Tadashi Ozawa Japan
T Shibuya Japan
S Okamoto Japan
N Monplaisir France
Liesbeth van Emst Netherlands View profile →
Citations per field, relative to M Sakurai
M Sakurai · 1×
Citations per year, relative to M Sakurai
M Sakurai · 1×

Countries citing papers authored by M Sakurai

Since Specialization
Citations

This map shows the geographic impact of M Sakurai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Sakurai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Sakurai more than expected).

Fields of papers citing papers by M Sakurai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Sakurai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Sakurai. The network helps show where M Sakurai may publish in the future.

Co-authorship network of co-authors of M Sakurai

This figure shows the co-authorship network connecting the top 25 collaborators of M Sakurai. A scholar is included among the top collaborators of M Sakurai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Sakurai. M Sakurai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 0
3 1
4 2
5 7
6 48
7 9
8 23
9 27
10 19
11
[The first case in Japan of unstable hemoglobin, Hb Buenos Aires [beta 85 (F1) Phe-->Ser], with parvovirus B19 infection (first case in Japan)].
0
12
[Influence of extracorporeal shock wave lithotripsy (ESWL) on renal function assessed by 99mTc-DMSA scintigraphy: comparative analysis between ESWL and percutaneous nephroureterolithotripsy (PNL)].
3
13
Clinical significance of chromosome abnormalities in childhood acute lymphoblastic leukemia in Japan.
23
14
[Sideroblastic anemia preceded by essential thrombocythemia with 20q- chromosome abnormality].
1
15 1
16 20
17 51
18
[Laboratory and clinical investigations of cefodizime in infectious diseases in childhood].
1
19
Discontinuing chemoimmunotherapy in childhood acute lymphoblastic leukemia.
6
20
Specific active immunotherapy in children with acute lympholastic leukemia and host immune responses against leukemic antigens.
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026